Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Tysabri® (natalizumab) data at ECTRIMS reaffirm positive effects of treatment for people with relapsing forms of MS
Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses.
Proteomics Urine Analysis of Pregnant Women Suffering from Multiple Sclerosis.
Vitamin D and multiple sclerosis-from epidemiology to prevention.
[Collaborative networks between Spain and Latin America regarding multiple sclerosis].
An atypical case of acute disseminated encephalomyelitis associated with cytomegalovirus infection.
The Case | The young philosopher with multiple sclerosis and proteinuria.
Multiple sclerosis: potential risk factors in childhood and adolescence.
Relapsing Remitting Multiple Sclerosis in an Iranian Patient with Neurofibromatosis Type I.
Axon regeneration impediment: the role of paired immunoglobulin-like receptor B.
Advances in the management of MS symptoms: recently proposed clinical management algorithms.
Enhanced accumulation of Kir4.1 protein, but not mRNA, in a murine model of cuprizone-induced demyelination.
Interferon-β Induces Hepatocyte Growth Factor in Monocytes of Multiple Sclerosis Patients.
CD24 gene allele variation is not associated with oligoclonal IgG bands and IgG index of multiple sclerosis patients.
Uphill and Downhill Walking in Multiple Sclerosis: A Randomized Controlled Trial.
Perceived Impact of a Self-Management Program for Fatigue in Multiple Sclerosis: A Qualitative Study.
TLR3 Agonist Poly-IC Induces IL-33 and Promotes Myelin Repair.
Axon damage in central nervous system and peripheral nervous system inflammatory demyelinating diseases: common and divergent pathways of dysfunction and tissue damage.
In Vivo Visualization of (Auto)Immune Processes in the Central Nervous System of Rodents.
Effect of intrahippocampal administration of vitamin C and progesterone on learning in a model of multiple sclerosis in rats.
Should patients with optic neuritis be treated with steroids?
Monthly oral methylprednisolone pulse treatment in progressive multiple sclerosis.
S1P1 deletion in oligodendroglial lineage cells: Effect on differentiation and myelination.
KV1 channels identified in rodent myelinated axons, linked to Cx29 in innermost myelin: Support for electrically-active myelin in mammalian saltatory conduction.
The putative acceleration of optic neuritis when combined with chronic hepatitis B.
Pages
« first
‹ previous
…
687
688
689
690
691
692
693
694
695
…
next ›
last »